Innovation
4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 28 times.
| Year | Filings |
|---|---|
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developer of opioid-based therapeutics for mood and depression disorders
4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 28 times.
| Year | Filings |
|---|---|
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |